CI
CELG

Cigna Investments’s Celgene Corp CELG Stock Holding History

Cigna Investments’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,727
Closed -$2.24M – 688
2019
Q3 		$2.24M Buy
20,727
+1,013
+5% +$96.3K 0.23% 89
2019
Q2 		$1.81M Sell
19,714
-554
-3% -$52.6K 0.2% 112
2019
Q1 		$1.91M Sell
20,268
-1,372
-6% -$120K 0.21% 95
2018
Q4 		$1.39M Buy
21,640
+1,055
+5% +$77.9K 0.12% 125
2018
Q3 		$1.47M Sell
20,585
-2,239
-10% -$198K 0.12% 132
2018
Q2 		$1.81M Sell
22,824
-27,070
-54% -$2.25M 0.13% 112
2018
Q1 		$4.45M Buy
49,894
+11,793
+31% +$1.13M 0.3% 48
2017
Q4 		$3.98M Sell
38,101
-1,089
-3% -$123K 0.26% 52
2017
Q3 		$5.71M Sell
39,190
-2,665
-6% -$363K 0.38% 38
2017
Q2 		$5.44M Sell
41,855
-5,698
-12% -$698K 0.37% 37
2017
Q1 		$5.92M Buy
47,553
+15,205
+47% +$1.82M 0.41% 35
2016
Q4 		$3.74M Buy
+32,348
New +$3.6M 0.41% 44

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Cigna Investments's CELG Position: Q4 2019 in Review

Cigna Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 20,727 shares — an estimated $2.24M sold.

Cigna Investments first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $5.92M in Q1 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cigna Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cigna Investments sold 20,727 Celgene Corp shares in Q4 2019, an estimated $2.24M.
  • Cigna Investments first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Cigna Investments's Celgene Corp position peaked at $5.92M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cigna Investments's 13F filing for Q4 2019, filed 4 Feb 2020.